stockrow
Tuesday 3 November 2026
Export ALHC’s income statement to Excel — free account
Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024.
- Revenue
- +36.7%
- EPS
- −293.0%
- Free cash flow
- −72.3%
- Total debt
- +0.55%
Quarter to September 2026, against a year earlier
7.18
0.18
+2.57%
Follow ALHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 160.18 | 113.38 | 53.90 |
P/S ratio |
0.99 | 0.85 | 1.08 | 0.34 | |
P/FCF ratio |
34.54 | 16.00 | 27.83 | 22.09 | |
P/Operating CF |
(77.63) | 28.12 | (285.28) | 36.19 | |
P/B ratio |
21.81 | 17.49 | 18.63 | 6.14 | |
Price to Tangible BV |
27.41 | 21.25 | 21.61 | 7.08 | |
EV/Sales |
0.92 | 0.76 | 1.00 | 0.26 | |
EV/EBITDA |
79.46 | 48.01 | 52.06 | 16.76 | |
EV/Operating CF |
25.95 | 12.77 | 22.20 | 11.90 | |
EV/FCF |
32.07 | 14.22 | 25.71 | 16.68 | |
Quick Ratio |
1.54 | 1.39 | 1.46 | 1.43 | |
Current Ratio |
1.71 | 1.58 | 1.70 | 1.71 | |
Net Debt/EBITDA |
123.97 | (17.04) | (7.48) | (86.53) | |
Debt/Assets |
30.32% | 25.65% | 25.34% | 25.02% | |
Debt/Equity |
1.80 | 1.56 | 1.22 | 1.17 | |
Asset Turnover |
4.27 | 3.95 | 4.02 | 4.12 | |
Operating CF/Net income |
4.58 | 11.27 | (0.47) | (5.84) | |
Capex/Depreciation |
(0.63) | (0.91) | (1.21) | (0.98) | |
Interest Coverage |
(2.60) | 3.82 | 9.85 | (0.89) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.42% | 9.81% | 9.81% | 10.04% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
1.29% | 1.13% | 1.36% | 1.29% | |
Graham Net Nets |
0.02 | 0.03 | 0.03 | 0.09 | |
Graham Number |
0.00 | 1.58 | 2.46 | 2.13 | |
Earnings Yield |
0.00% | 0.62% | 0.88% | 1.86% | |
Free Cash Flow Yield |
2.90% | 6.25% | 3.59% | 4.53% | |
Revenue per Share |
5.12 | 6.01 | 6.44 | 6.51 | |
Operating CF per Share |
(0.25) | 0.63 | (0.08) | 0.23 | |
Capex per Share |
(0.03) | (0.04) | (0.05) | (0.04) | |
Free Cash Flow per Share |
(0.28) | 0.59 | (0.13) | 0.19 | |
Cash per Share |
3.05 | 3.54 | 3.38 | 3.56 | |
Shareholders Equity per Share |
0.91 | 1.01 | 1.28 | 1.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.91 | 1.01 | 1.28 | 1.33 | |
Free Cash Flow |
(55.40) | 121.32 | (27.46) | 38.58 | |
Working Capital |
394.71 | 420.61 | 477.04 | 489.26 | |
Capital Expenditures |
(5.03) | (7.36) | (10.14) | (8.44) | |
Net Current Asset Value |
65.07 | 90.64 | 146.54 | 158.56 | |
EV/EBIT |
246.15 | 90.25 | 82.97 | 29.52 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
265.09 | 101.50 | 89.81 | 39.10 | |
| Other line items | |||||
Average Receivables |
203.56 | 245.87 | 289.91 | 231.19 | |
Average Payables |
409.88 | 557.62 | 565.76 | 609.56 | |
Average Assets |
923.92 | 1,078.61 | 1,139.59 | 1,199.74 | |
Average Common Equity |
140.12 | 157.94 | 203.05 | 219.49 |
Columns are period end dates · fundamentals updated 2 Nov 2026